12 November 2025

pharmaceutical Psoriasis

Biologic-level psoriasis control without injections

9 July 2025

Hidradenitis Suppurativa PBS

PBS recommendations for bimekizumab, guselkumab

14 May 2025

Dermatology Psoriasis Research

Foam treatment reduces scalp and body psoriasis

11 December 2024

Dermatology

Top 10 Dermatology Republic stories for 2024: see what made the list

24 July 2024

Clinical Psoriasis

Broader access to plaque psoriasis drug welcomed

15 November 2023

pharmaceutical psoriatic arthritis

Anti-JAKs safe in skin conditions

2 November 2023

Paediatrics PBS pharmaceutical

PBS cuts etanercept red tape

4 October 2023

Patients Psoriasis psoriatic arthritis

Psoriasis management resources to empower your patients

12 October 2022

Psoriasis psoriatic arthritis

One size does not fit all

28 September 2022

pharmaceutical Psoriasis

Deucravacitinib FDA approved for plaque psoriasis

17 August 2022

Psoriasis

Hope for new plaque psoriasis treatment

17 August 2022

Psoriasis

Fortnightly secukinumab better for heavier psoriasis patients

20 June 2022

Arthritis COVID-19 Psoriasis psoriatic arthritis

Rituximab and non-white ethnicity linked with worse covid outcomes

27 April 2022

Clinical Psoriasis

Psoriasis drug passes another milestone